77 related articles for article (PubMed ID: 13977)
21. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs.
Ji-qun C; Ishihara K; Nagayama T; Serikawa T; Sasa M
Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430
[TBL] [Abstract][Full Text] [Related]
22. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
23. Phenobarbital metabolism by hepatocytes isolated from rat.
Vérité P; Cavé C; Ménager S; Davy J; André D; Farnoux CC; Lafont O
Drug Metabol Drug Interact; 1996; 13(1):41-55. PubMed ID: 8902430
[TBL] [Abstract][Full Text] [Related]
24. Quantitation of phenobarbital and its main metabolites in human urine.
Kallberg N; Agurell S; Ericsson O; Bucht E; Jalling B; Boréus LO
Eur J Clin Pharmacol; 1975 Dec; 9(2-3):161-8. PubMed ID: 1233264
[TBL] [Abstract][Full Text] [Related]
25. Determination of the sulphoxides and sulphones of three simple sulphides in rat urine: effects of phenobarbitone, beta-naphthoflavone and methimazole.
Nnane IP; Damani LA
Biomed Chromatogr; 2005 Jan; 19(1):87-98. PubMed ID: 15470701
[TBL] [Abstract][Full Text] [Related]
26. Altered aromatic amine metabolism in epileptic patients treated with phenobarbital.
Wallin H; Skipper PL; Tannenbaum SR; Jensen JP; Rylander L; Olsen JH
Cancer Epidemiol Biomarkers Prev; 1995; 4(7):771-3. PubMed ID: 8672995
[TBL] [Abstract][Full Text] [Related]
27. Metabolism and excretion of a new anxiolytic drug candidate, CP-93, 393, in healthy male volunteers.
Prakash C; Cui D; Baxter JG; Bright GM; Miceli J; Wilner K
Drug Metab Dispos; 1998 May; 26(5):448-56. PubMed ID: 9571226
[TBL] [Abstract][Full Text] [Related]
28. Metabolism of the proestrogenic pesticide methoxychlor by hepatic P450 monooxygenases in rats and humans. Dual pathways involving novel ortho ring-hydroxylation by CYP2B.
Dehal SS; Kupfer D
Drug Metab Dispos; 1994; 22(6):937-46. PubMed ID: 7895613
[TBL] [Abstract][Full Text] [Related]
29. Urinary metabolites of phenobarbitone, primidone, and their N-methyl and N-ethyl derivatives in humans.
Treston AM; Hooper WD
Xenobiotica; 1992 Apr; 22(4):385-94. PubMed ID: 1523859
[TBL] [Abstract][Full Text] [Related]
30. Neurocognitive effects of phenobarbital discontinuation in epileptic children.
Tonekaboni SH; Beyraghi N; Tahbaz HS; Bahreynian SA; Aghamohammadpoor M
Epilepsy Behav; 2006 Feb; 8(1):145-8. PubMed ID: 16266827
[TBL] [Abstract][Full Text] [Related]
31. Kinetics of drug action in disease states. I. Effect of infusion rate on phenobarbital concentrations in serum, brain and cerebrospinal fluid of normal rats at onset of loss of righting reflex.
Danhof M; Levy G
J Pharmacol Exp Ther; 1984 Apr; 229(1):44-50. PubMed ID: 6707947
[TBL] [Abstract][Full Text] [Related]
32. A novel mechanism for the enhancement of acetaminophen hepatotoxicity by phenobarbital.
Douidar SM; Ahmed AE
J Pharmacol Exp Ther; 1987 Feb; 240(2):578-83. PubMed ID: 3806412
[TBL] [Abstract][Full Text] [Related]
33. Biotransformation and elimination of 14C-flecainide acetate in humans.
McQuinn RL; Quarfoth GJ; Johnson JD; Banitt EH; Pathre SV; Chang SF; Ober RE; Conard GJ
Drug Metab Dispos; 1984; 12(4):414-20. PubMed ID: 6148206
[TBL] [Abstract][Full Text] [Related]
34. Effect of microsomal enzyme inducers on the urinary excretion pattern of mutagenic metabolites of the carcinogen 2,4-toluenediamine.
Reddy TV; Ramanathan R; Benjamin T; Grantham PH; Weisburger EK
J Natl Cancer Inst; 1986 Feb; 76(2):291-7. PubMed ID: 3456067
[TBL] [Abstract][Full Text] [Related]
35. Kinetics of phenobarbital in normal subjects and epileptic patients.
Wilensky AJ; Friel PN; Levy RH; Comfort CP; Kaluzny SP
Eur J Clin Pharmacol; 1982; 23(1):87-92. PubMed ID: 7128675
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of phenobarbital following single and repeated doses.
Viswanathan CT; Booker HE; Welling PG
J Clin Pharmacol; 1979; 19(5-6):282-9. PubMed ID: 469023
[TBL] [Abstract][Full Text] [Related]
37. High-performance liquid chromatographic analysis of phenobarbital and phenobarbital metabolites in human urine.
Paibir SG; Soine WH
J Chromatogr B Biomed Sci Appl; 1997 Mar; 691(1):111-7. PubMed ID: 9140764
[TBL] [Abstract][Full Text] [Related]
38. Studies with stable isotopes II: Phenobarbital pharmacokinetics during monotherapy.
Browne TR; Evans JE; Szabo GK; Evans BA; Greenblatt DJ
J Clin Pharmacol; 1985; 25(1):51-8. PubMed ID: 3973064
[TBL] [Abstract][Full Text] [Related]
39. Interference by p-hydroxyphenobarbital in the 125I-radioimmunoassay of serum and urinary phenobarbital.
Viswanathan CT; Booker HE; Welling PG
Clin Chem; 1977 May; 23(5):873-6. PubMed ID: 852110
[TBL] [Abstract][Full Text] [Related]
40. GC and GC-mass spectrometric determination of p-hydroxyphenobarbital extracted from plasma, urine, and hepatic microsomes.
Kapetanović IM; Kupferberg HJ
J Pharm Sci; 1981 Nov; 70(11):1218-24. PubMed ID: 7299667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
